Oman - Re-Export of Vaccines for Human Use
Since 2011, Oman Re-Export of Vaccines for Human Use fell by 25% year on year. In 2016, the country was number 15 comparing other countries in Re-Export of Vaccines for Human Use with $24,790.64. Oman is overtaken by Mauritius, which was ranked number 14 at $32,503.62 and is followed by Antigua and Barbuda with $20,516. United States ranked the highest with $21,386,560.62 in 2019, -18% compared to 2018. United Arab Emirates, Canada and Saudi Arabia respectively ranked number 2, 3 and 4 in this ranking. Guyana witnessed the best average annual growth at +106.5% per year, while Trinidad and Tobago recorded the worst performance at -49.8% per year.
Loading...
Date | US Dollars |
---|---|
2016 | 24,790.63 |
2015 | |
2014 | |
2013 | 99,594.00 |
2012 | 76,263.00 |
Download all data from 2005 to 2016
How does Oman rank in Re-Export of Vaccines for Human Use?
# | 22 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
United States
|
21,386,560.62 | 2019 | -18.0 % | -6.8 % | View data | |
2 |
#2
United Arab Emirates
|
7,990,507.15 | 2019 | +36.5 % | +27.7 % | View data | |
14 |
#14
Mauritius
|
32,503.62 | 2019 | +4.6 % | +47.3 % | View data | |
15 |
#15
Oman
|
24,790.63 | 2016 | NA | -25.0 % | View data | |
16 |
#16
Antigua and Barbuda
|
20,516.00 | 2019 | +5.8 % | +51.1 % | View data |